Literature DB >> 3484349

Erythromycin series. XII. Antibacterial in vitro evaluation of 10-dihydro-10-deoxo-11-azaerythromycin A: synthesis and structure-activity relationship of its acyl derivatives.

S Djokić, G Kobrehel, G Lazarevski.   

Abstract

Antibacterial in vitro evaluation of 10-dihydro-10-deoxo-11-azaerythromycin A (5), the new 15-membered semi-synthetic macrolide antibiotic with nitrogen as additional atom in the aglycone ring of erythromycin A (1), was reported. Although amine (5) and its 13,14-cyclic carbonate (14) were less active than 1 against erythromycin-sensitive Staphylococcus aureus strains they showed advantageous properties against Gram-negative test organisms and clinical isolates. Also, a large number of acyl derivatives of 5 were synthesized and evaluated. N-11 monoacyl compounds exhibited 2 to 50 times lower in vitro antibacterial efficacy than the parent amine (5).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3484349     DOI: 10.7164/antibiotics.40.1006

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  6 in total

Review 1.  New directions for macrolide antibiotics: structural modifications and in vitro activity.

Authors:  H A Kirst; G D Sides
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Chemistry and biology of macrolide antiparasitic agents.

Authors:  Younjoo Lee; Jun Yong Choi; Hong Fu; Colin Harvey; Sandeep Ravindran; William R Roush; John C Boothroyd; Chaitan Khosla
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

3.  Cell handling, membrane-binding properties, and membrane-penetration modeling approaches of pivampicillin and phthalimidomethylampicillin, two basic esters of ampicillin, in comparison with chloroquine and azithromycin.

Authors:  Hugues Chanteux; Isabelle Paternotte; Marie-Paule Mingeot-Leclercq; Robert Brasseur; E Sonveaux; Paul M Tulkens
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

Review 4.  Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.

Authors:  D H Peters; H A Friedel; D McTavish
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

5.  The macrolide antibiotic azithromycin interacts with lipids and affects membrane organization and fluidity: studies on Langmuir-Blodgett monolayers, liposomes and J774 macrophages.

Authors:  D Tyteca; A Schanck; Y F Dufrêne; M Deleu; P J Courtoy; P M Tulkens; M P Mingeot-Leclercq
Journal:  J Membr Biol       Date:  2003-04-01       Impact factor: 1.843

6.  Azithromycin Protects against Zika virus Infection by Upregulating virus-induced Type I and III Interferon Responses.

Authors:  Chunfeng Li; Shulong Zu; Yong-Qiang Deng; Dapei Li; Kislay Parvatiyar; Natalie Quanquin; Jingzhe Shang; Nina Sun; Jiaqi Su; Zhenyang Liu; Min Wang; Saba R Aliyari; Xiao-Feng Li; Aiping Wu; Feng Ma; Yi Shi; Karin Nielsevn-Saines; Jae U Jung; Frank Xiao-Feng Qin; Cheng-Feng Qin; Genhong Cheng
Journal:  Antimicrob Agents Chemother       Date:  2019-09-16       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.